E-LIB Suche - Ergebnisse für: Tijtgat, J

1

Intratumoral administration of the immunologic adjuvant AS0..:

Tijtgat, Jens ; Geeraerts, Xenia ; Boisson, Anais...
Journal for ImmunoTherapy of Cancer. 12 (2024) 1 - p. e008148 , 2024

Link: https://doi.org/10.1136/..

2

A randomized phase II clinical trial of stereotactic body r..:

Vounckx, Manon ; Tijtgat, Jens ; Stevens, Latoya...
Cancer Immunology, Immunotherapy. 73 (2024) 9 - p. , 2024

Link: https://doi.org/10.1007/..

3

Intratumoral administration of the immunologic adjuvant AS0..:

Tijtgat, Jens ; Geeraerts, Xenia ; Boisson, Anais...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806541/. , 2024

Link: http://www.ncbi.nlm.nih...

4

Intratumoral administration of the immunologic adjuvant AS0..:

Bart Neyns ; Julia Katharina Schwarze ; Karen Willard-Gallo...
https://jitc.bmj.com/content/12/1/e008148.full. , 2024

Link: https://doi.org/10.1136/..

5

P06.18.B OVERVIEW OF THE GLITIPNI TRIAL - LOCAL ADMINISTRAT..:

Duerinck, J ; Tijtgat, J ; Dirven, I...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii49-ii50 , 2023

Link: https://doi.org/10.1093/..

6

P136 ECFS syllabuses for the multidisciplinary team and wid..:

Smith, C. ; Chadwick, H.K ; Farinha, C....
Journal of Cystic Fibrosis. 22 (2023) - p. S106 , 2023

Link: https://doi.org/10.1016/..

7

Low-Dose Bevacizumab for the Treatment of Focal Radiation N..:

Tijtgat, Jens ; Calliauw, Evan ; Dirven, Iris...
Cancers. 15 (2023) 9 - p. 2560 , 2023

Link: https://doi.org/10.3390/..

8

694 A randomized phase II clinical trial of SBRT and pembro..:

Bart Neyns ; Bart Ilsen ; Jens Tijtgat...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..

9

Low-Dose Bevacizumab for the Treatment of Focal Radiation N..:

Jens Tijtgat ; Evan Calliauw ; Iris Dirven...
Cancer Therapy. , 2023

Link: https://doi.org/10.3390/..

10

Low-Dose Bevacizumab for the Treatment of Focal Radiation N..:

Jens Tijtgat ; Evan Calliauw ; Iris Dirven...
https://www.mdpi.com/2072-6694/15/9/2560. , 2023

Link: https://doi.org/10.3390/..

11

Intratumoral administration of CD1c (BDCA-1)+and CD141 (BDC..:

Schwarze, Julia Katharina ; Tijtgat, Jens ; Awada, Gil...
Journal for ImmunoTherapy of Cancer. 10 (2022) 9 - p. e005141 , 2022

Link: https://doi.org/10.1136/..

12

Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET ..:

Geens, W. ; Du Four, S. ; Van Laere, S....
Brain and Spine. 2 (2022) - p. 101503 , 2022

Link: https://doi.org/10.1016/..

13

P06.05.A Repeated intracranial administration of ipilimumab..:

Geens, W ; Schwarze, J K ; Awada, G...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii38-ii39 , 2022

Link: https://doi.org/10.1093/..

14

CTIM-12. A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMIN..:

Geens, Wietse ; Schwarze, Julia Katharina ; Tijtgat, Jens...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii62-vii62 , 2022

Link: https://doi.org/10.1093/..

15

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant T..:

Schwarze, Julia Katharina ; Garaud, Soizic ; Jansen, Yanina J. L....
Cancers. 14 (2022) 3 - p. 682 , 2022

Link: https://doi.org/10.3390/..